Jerome A. Zack

21.6k citations

189 papers · 16.5k indexed · 5 hit papers · h-index 63

Impact in

Virology top 0.02%
- HIV Research and Treatment
Immunology top 0.1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in

Virology 126
- HIV Research and Treatment 126
Immunology 107
- Immune Cell Function and Interaction 86
- T-cell and B-cell Immunology 26

Co-authors: Irvin S. Y. Chen Scott G. Kitchen Yael Korin Beth D. Jamieson Allyson M. Haislip Matthew D. Marsden Salvatore J. Arrigo Stacy Weitsman
Journals: Journal of Virology (45 papers)Proceedings of the National Academy of Sciences (10 papers)AIDS Research and Human Retroviruses (9 papers)Virology (7 papers)The Journal of Immunology (5 papers)
Partner nations: United States Poland France

In The Last Decade

Jerome A. Zack

185 papers receiving 16.2k citations

Hit Papers

5 papers align trajectories log scale

Interferon-Inducible Cholesterol-25-Hydroxylase Broadly Inhibits Viral Entry by Production of 25-Hydroxycholesterol 2012 · 516 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 Immunity
2001 Science
1998 Nature
1990 Nature
1990 Cell

Peers

Countries citing papers authored by Jerome A. Zack

Since Specialization

Citations

This map shows the geographic impact of Jerome A. Zack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome A. Zack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome A. Zack more than expected).

Fields of papers citing papers by Jerome A. Zack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome A. Zack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome A. Zack. The network helps show where Jerome A. Zack may publish in the future.

Co-authors

The 25 scholars most cited alongside Jerome A. Zack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jerome A. Zack Line = papers co-authored together Jerome A. Zack links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Author Correction: Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns Nature Communications ·Tian-hao Zhang, Yuan Shi, Natalia L. Komarova, Dominik Wodarz, Matthew Kostelny, Albert L. Gonzales, Izra Abbaali, Hongying Chen, Gabrielle Bresson-Tan, Melanie Dimapasoc, William T. Harvey, Christopher Oh, Camille Carmona, Christopher S. Seet, Yushen Du, Ren Sun, Jerome A. Zack, Jocelyn T. Kim	2025	0
2	Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells SHILAP Revista de lepidopterología ·Melanie Dimapasoc, Jose A. Moran, Steve Cole, Alok Ranjan, Rami Hourani, Jocelyn T. Kim, Paul A. Wender, Matthew D. Marsden, Jerome A. Zack	2024	2
3	Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window Proceedings of the National Academy of Sciences ·Jack L. Sloane, Nancy L. Benner, Katherine E. Near, Xiaoyu Zang, Mohamed S. Soliman, Xiaomeng Wu, Melanie Dimapasoc, Tae‐Wook Chun, Matthew D. Marsden, Jerome A. Zack, Paul A. Wender	2020	44
4	Tracking HIV Rebound following Latency Reversal Using Barcoded HIV Cell Reports Medicine ·Matthew D. Marsden, Tianhao Zhang, Yushen Du, Melanie Dimapasoc, Mohamed S. Soliman, Xiaomeng Wu, Jocelyn T. Kim, Akira Shimizu, Adam J. Schrier, Paul A. Wender, Ren Sun, Jerome A. Zack	2020	19
5	Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo Cell Reports Medicine ·Lars Pache, Matthew D. Marsden, Peter Teriete, Alex J. Portillo, Dominik Heimann, Jocelyn T. Kim, Mohamed S. Soliman, Melanie Dimapasoc, Camille Carmona, Maria Celeridad, Adam M. Spivak, Vicente Planelles, Nicholas D. P. Cosford, Jerome A. Zack, Sumit K. Chanda	2020	38
6	Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy Nature Communications ·Clayton Hardman, Stephen Ho, Akira Shimizu, Quang H. Luu-Nguyen, Jack L. Sloane, Mohamed S. Soliman, Matthew D. Marsden, Jerome A. Zack, Paul A. Wender	2020	37
7	Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging Journal of Clinical Investigation ·Melissa McCracken, Dimitrios N. Vatakis, Dhaval Dixit, Jami McLaughlin, Jerome A. Zack, Owen N. Witte	2015	29
8	HIV Latency in the Humanized BLT Mouse Journal of Virology ·Matthew D. Marsden, Michael Kovochich, Nuttee Suree, Saki Shimizu, Roshni Mehta, Ruth Cortado, Gregory Bristol, Dong Sung An, Jerome A. Zack	2011	93
9	Activation of Latent HIV Using Drug-Loaded Nanoparticles PLoS ONE ·Michael Kovochich, Matthew D. Marsden, Jerome A. Zack	2011	69
10	Differential expression and interaction of host factors augment HIV-1 gene expression in neonatal mononuclear cells Virology ·Vasudha Sundaravaradan, Roshni Mehta, David T. Harris, Jerome A. Zack, Nafees Ahmad	2010	11
11	Macrophage differentiation from embryoid bodies derived from human embryonic stem cells. PubMed ·Aparna Subramanian, Beichu Guo, Matthew D. Marsden, Zoran Galić, Scott G. Kitchen, Amelia Kacena, Helen Brown, Genhong Cheng, Jerome A. Zack	2009	14
12	CD4+ NK cells can be productively infected with HIV, leading to downregulation of CD4 expression and changes in function Virology ·Helene B. Bernstein, Guangwu Wang, Mary C. Plasterer, Jerome A. Zack, Parthasarathy Ramasastry, Shannon M. Mumenthaler, Christina M. Ramirez	2009	31
13	T lineage differentiation from human embryonic stem cells Proceedings of the National Academy of Sciences ·Zoran Galić, Scott G. Kitchen, Amelia Kacena, Aparna Subramanian, Bryan Burke, Ruth Cortado, Jerome A. Zack	2006	110
14	Retrocyclin: A primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1 Proceedings of the National Academy of Sciences ·Alexander M. Cole, Teresa Hong, Lee Ming Boo, Tung Nguyen, Chengquan Zhao, Greg Bristol, Jerome A. Zack, Alan J. Waring, Otto O. Yang, Robert I. Lehrer	2002	238
15	レトロサイクリン HIV‐1のT‐及びM‐親和性株による感染から細胞を保護する霊長類ペプチド Proc Natl Acad Sci USA ·Ayeisha Cole, Ting Hong, Boo L M, Thuy Thi Vu Nguyen, Chen Zhao, Greg Bristol, Jerome A. Zack, Otto O. Yang, Robert I. Lehrer	2002	96
16	Negative Regulation of Neural Stem/Progenitor Cell Proliferation by the Pten Tumor Suppressor Gene in Vivo Science ·Matthias Groszer, Rebecca J. Erickson, Deirdre D. Scripture-Adams, Ralf Lesche, Andreas Trumpp, Jerome A. Zack, Harley I. Kornblum, Xin Liu, Hong Wu Hit paper breakdown →	2001	664
17	Isolation of mycobacterium-reactive CD1-restricted T cells from patients with human immunodeficiency virus infection. Journal of Clinical Investigation ·Jianhua Gong, Steffen Stenger, Jerome A. Zack, B E Jones, Greg Bristol, Robert L. Modlin, P J Morrissey, Peter F. Barnes	1998	29
18	Effects of Megakaryocyte Growth and Development Factor on Survival and Retroviral Transduction of T Lymphoid Progenitor Cells Human Gene Therapy ·Rafael G. Amado, Geoff Symonds, Beth D. Jamieson, Grace Zhao, Joseph D. Rosenblatt, Jerome A. Zack	1998	10
19	HIV-1 Reverse Transcription in Cord Blood Lymphocytes: Implications for Infection of Newborns AIDS Research and Human Retroviruses ·Paul Krogstad, Jerome A. Zack, Irvin S. Y. Chen	1994	4
20	Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). Journal of Clinical Investigation ·Elizabeth A. Rich, I S Chen, Jerome A. Zack, Michelle L. Leonard, William A. O’Brien	1992	194

About Jerome A. Zack

Jerome A. Zack is a scholar working on Virology, Immunology, Infectious Diseases, Oncology and Epidemiology, having authored 189 papers that have together received 16.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (126 papers), Immune Cell Function and Interaction (86 papers), HIV/AIDS drug development and treatment (43 papers), T-cell and B-cell Immunology (26 papers), HIV/AIDS Research and Interventions (23 papers), Virus-based gene therapy research (21 papers), CAR-T cell therapy research (21 papers) and Cytomegalovirus and herpesvirus research (21 papers). The work is most often cited by research in Virology (8.8k citations), Immunology (7.2k citations), Infectious Diseases (4.7k citations), Biological Psychiatry (246 citations) and Epidemiology (2.6k citations). Jerome A. Zack has collaborated with scholars based in United States, Poland and France. Frequent co-authors include Irvin S. Y. Chen, Scott G. Kitchen, Yael Korin, Beth D. Jamieson, Allyson M. Haislip, Matthew D. Marsden, Salvatore J. Arrigo, Stacy Weitsman, Alan S. Go and Deirdre D. Scripture-Adams. Their work appears in journals such as Journal of Virology, Proceedings of the National Academy of Sciences, AIDS Research and Human Retroviruses, Virology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact